Home » Stocks » H-CYTE, Inc.


Stock Price: $0.0149 USD 0.0000 (-0.67%)
Updated Oct 20, 2020 1:45 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.82M
Revenue (ttm) 5.63M
Net Income (ttm) -29.66M
Shares Out 122.14M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 20, 2020
Last Price $0.0149
Previous Close $0.0150
Change ($) 0.0000
Change (%) -0.67%
Day's Open 0.0149
Day's Range 0.0149 - 0.0149
Day's Volume 32,953
52-Week Range 0.014 - 0.299

More Stats

Market Cap 1.82M
Enterprise Value 1.73M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 122.14M
Float 61.60M
EPS (basic) -0.33
EPS (diluted) -0.33
FCF / Share -0.10
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 253,311
Short Ratio 5.33
Short % of Float 0.41%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.32
PB Ratio 1.90
Revenue 5.63M
Operating Income -26.39M
Net Income -29.66M
Free Cash Flow -10.04M
Net Cash 87,120
Net Cash / Share 0.00
Gross Margin 111.85%
Operating Margin -468.99%
Profit Margin -584.40%
FCF Margin -178.45%
ROA -59.20%
ROE -1,647.08%
ROIC 1,330.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $0.0149
Target: 1.75
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth5.88%3701.95%----
Gross Profit6.295.520.04---
Operating Income-30.56-4.19-6.06-12.86-5.54-2.94
Net Income-29.81-4.39--16.23-6.52-2.94
Shares Outstanding96.3733.6619.1413.2510.947.90
Earnings Per Share-0.34-0.13-0.34-1.22-0.60-0.37
Operating Cash Flow-12.29-3.54-5.59-5.43-5.98-2.76
Capital Expenditures-0.02-0.01-0.02-0.09-0.01-0.02
Free Cash Flow-12.31-3.56-5.61-5.51-5.99-2.78
Cash & Equivalents1.420.070.250.901.576.68
Total Debt2.444.490.171.201.05-
Net Cash / Debt-1.02-4.420.08-0.300.526.68
Book Value-9.09-5.700.71-0.4510.026.51
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name H-CYTE, Inc.
Country United States
CEO Robert Greif

Stock Information

Ticker Symbol HCYT
Stock Exchange US OTC
Sector Healthcare
Industry Medical Devices
Unique Identifier OTCMKTS: HCYT


H-CYTE, a medical biosciences company, develops and implements various treatment options in regenerative medicine to treat chronic lung diseases. It engages in the development of L-CYTE-01 for the treatment of chronic obstructive pulmonary diseases. The company is headquartered in Tampa, Florida.